Top 0 Biotech & Drug Developers Companies $100M+ Revenue (November 2026)
As of November 2026, Latka tracks 0 biotech & drug developers companies with $100M+ in annual revenue.
Every company below is ranked by its most recent annual revenue. Revenue, funding, headcount and customer figures come from CEO interviews on the Latka podcast, public company filings, and Latka estimates where a company has not disclosed a number.
What Biotech & Drug Developers Companies do
Biotech and drug developers discover and develop their own medicines: AI-first drug discovery companies with internal pipelines, antibody and small-molecule developers, and clinical-stage biotechs that partner programs with pharma.
- Companies
- 0
- Revenue
- -
- Funding
- -
- Employees
- -
Filters
Sorting: Highest -> Lowest
Top Biotech & Drug Developers Companies $100M+ Revenue
Showing 0 of 0 companies ranked by annual revenue.
Related Services categories
Inclusion Criteria
- Must develop its own drug candidates or therapeutics as its main business - May license its discovery platform to pharma partners - Software sold to drug developers belongs in Pharma and Biotech Software or Drug Discovery Software